期刊文献+

前列地尔对糖尿病肾病尿清蛋白排泄率、血小板活化和血脂的影响 被引量:24

Effect of alprostadil on urinary albumin excretion rate,platelet activation and blood lipid in patients with diabetic nephropathy
下载PDF
导出
摘要 目的 :观察静脉应用前列地尔对老年糖尿病肾病尿清蛋白排泄率、血小板活化和血脂的影响。方法 :老年糖尿病肾病 76例 ,男性 4 8例 ,女性 2 8例 ,分为治疗组 4 0例和对照组 36例 ,2组均行常规治疗控制血糖、血压和血脂。治疗组加用前列地尔10 μg ,iv ,gtt ,每日 1次 ,2组疗程均为 14d。结果 :治疗后 ,治疗组尿清蛋白排泄率、血小板活化水平均下降 ,与治疗前、与对照组比较 ,差异有非常显著意义 (P <0 .0 1)。血肌酐由治疗前 (14 3±s 16 ) μmol·L- 1下降到 (96± 10 ) μmol·L- 1(P <0 .0 1) ,血脂变化与对照组无差异。结论 :静脉短期使用前列地尔能减少尿清蛋白排泄率 ,降低血小板活化 ,抑制血细胞粘附 ,降低血肌酐水平。 AIM: To observe the effect of alprostadil on urinary albumin excretion rate(UAER),platelet activation and blood lipid in old patients with diabetic nephropathy. METHODS: Seventy-six old patients with diabetic nephropathy (M 48,F 28) were divided into two groups: the treatment group( n =40) and the control group ( n =36). Patients in both groups were routinely treated to control blood glucose,blood pressure and blood lipid. Patients in treatment group were treated with intravenous infusion of alprostadil 10 μg qd for 14 d. RESULTS: After treatment,UAER and platelet activation of treatment group were both significantly reduced compared with those of the control group. In treatment group,creatinine decreased from (143± s 16)μmol·L -1 to (96±10)μmol·L -1 ( P <0.01). There were no significant differences in changes of blood lipid between two groups( P >0.05). CONCLUSION: Short-term intravenous infusion of alprostadil may decrease UAER, platelet activation,inhibit adhesiveness of platelet and leucocyte,and reduce the level of creatinine.
出处 《中国新药与临床杂志》 CAS CSCD 北大核心 2004年第7期409-411,共3页 Chinese Journal of New Drugs and Clinical Remedies
关键词 前列地尔 糖尿病肾病 血小板活化 膜蛋白质类 alprostadil diabetic nephropathies platelet activation membrane proteins
  • 相关文献

参考文献5

二级参考文献21

  • 1邹立军,李媛明,韩会芹,庄庆媛,刘海燕,宋亚贵.前列腺素E_1治疗糖尿病64例临床观察[J].吉林医学,1994,15(1):29-30. 被引量:13
  • 2American Diabetes Association. Diabetic nephropathy. Diabetes Care, 2000,25(Suppl 1):S85-S89.
  • 3Mogensen CE. Microalbuminuria as a risk marker in diabetic and non-diabetic patients . Diabetes Res Clin Pract, 2002,56(Suppl 1):S9.
  • 4Tan Y, Yang YN, Zhang ZG, et al. Urinary type Ⅳ collagen: a specific indicator of incipient diabetic nephropathy. Chin Med J, 2002,115:389-394.
  • 5DeFronzo RA. Diabetes renal disease. In: Porte D Jr. and Sherwin RS (eds). Ellenberg & Rifkin′s Diabetes Mellitus (5th ed). Beijing, China: McGraw-Hill, 1998.971-1008.
  • 6Diercks GF, Stroes ES, Boven AJ, et al. Urinary albumin excretion is related to cardiovascular risk indicators, not to flow-mediated vasodilation, in apparently healthy subjects. Atherosclerosis, 2002,163:121-126.
  • 7Diercks GF, van Boven AJ, Hillege JL, et al. The importance of microalbuminuria as a cardiovascular risk indicator: A review. Can J Cardiol, 2000,18:525-535.
  • 8前言[J].中国糖尿病杂志,2001,9.
  • 9杨钢,内分泌生理与病理生理学,1996年,426页
  • 10杨乃龙,中华器官移植杂志,1993年,14卷,159页

共引文献473

同被引文献137

引证文献24

二级引证文献149

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部